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W
ithout voltage-gated sodium chan-
nels, heart muscle cells can’t keep a 
beat. Lowe et al. show how these 
cells, known as cardiomyocytes, direct channels 
to the right domain of their plasma membrane.
Opening Nav1.5 sodium channels allows 
an inrush of sodium ions that depolarizes a 
cardiomyocyte. Patients who carry a faulty 
version of the channel are at risk for potentially 
lethal heart arrhythmias. Rather than scatter-
ing around the membrane, the channels home 
in on the junctions between cardiomyocytes. 
In neurons, the membrane skeletal protein 
ankyrin-G helps direct sodium channels to 
speciﬁ  c membrane domains, and Lowe et al. 
tested whether this ankyrin-based pathway 
performed the same function in heart cells.
When the researchers knocked down an-
kyrin-G using RNAi, they found that Nav1.5 resid-
ed around the nucleus instead of in the membrane. 
The amount of Nav1.5 in the cell also fell, possibly 
because wayward channels get degraded. After 
stimulation, cardiac muscle cells lacking ankyrin-G 
produced a smaller-than-normal current.
The knockdown of ankyrin-G had no effect 
on the location or activity of the cells’ primary 
voltage-gated calcium channel, suggesting that 
the targeting pathway in heart cells is speciﬁ  c 
for Nav1.5. By testing mutant forms of ankyrin-G 
that can’t bind to the channel, the team showed 
that interactions between the two proteins are 
necessary to get Nav1.5 into position.
The big question now is how ankyrin-G 
does the job. The protein might haul Nav1.5 to 
the membrane or stabilize channels that have 
already made it there. 
Reference: Lowe, J.S., et al. 2008. J. Cell Biol. 
180:173–186.
Genetic feng shui 
for cancer cells?
O
ne of the fi  rst things a cancer cell does is 
move around some of its genes, Meaburn 
and Misteli show.
Cells rearrange their DNA during certain diseases. 
In neurons from people with epilepsy, for instance, the 
X chromosome tends to be closer to the middle of the 
nucleus than in neurons from nonepileptics. Researchers 
have also observed chromosomal relocation in the 
few cancers they have examined. However, these 
observations involved late-stage disease, and no one 
knew what happened early in tumor development.
Meaburn and Misteli scrutinized mammary cells that 
they had coaxed to grow abnormally. When the research-
ers pinpointed 11 genes, they found that four—includ-
ing the antiapoptotic gene BCL2—were in different 
positions in the cancer cells than in normal cells. Three 
of the genes were closer to the edge of the nucleus in the 
tumor cells, and one was closer to the center.
Some studies suggest that active genes tend to 
shift into the interior of the nucleus, whereas inactive 
genes are marginalized. But the team determined that 
the location of a particular gene in the nucleus didn’t 
depend on its expression level. For example, activity 
of the gene for the extracellular matrix protein MMP1 
shot up in the cancerous cells, but the gene remained 
in place. The researchers conclude that early in tumor 
formation, cancer cells reposition certain genes. Why 
the cells go to the trouble is a mystery, but the 
discovery might lead to new diagnostic tests. 
Reference: Meaburn, K.J., and T. Misteli. 2008. J. Cell Biol. 
180:39–50.
Tuning up mitochondria for 
angiogenesis
D
uring angiogenesis, the protein pro-
hibitin-1 doesn’t live up to its name. 
Instead of stopping some cellular 
process, it encourages new blood vessel 
growth by ensuring that mitochondria run 
efﬁ ciently, as Schleicher et al. reveal.
For lower organisms, prohibitin-1 is an 
asset. It keeps mitochondria functioning 
smoothly, and its loss pushes cells into the 
low-activity, slow-dividing state called senes-
cence. The researchers suspected that pro-
hibitin-1 would do a similar job in mammals 
and might be particularly important for 
vascular homeostasis, since mitochondrial 
maintenance is known to be important for 
vascular health—reactive oxygen species 
(ROS) that spill out from malfunctioning mitochondria can damage 
endothelial cells and prompt atherosclerosis.
The team knocked down the protein in mammalian endothelial 
cells and found that the cells’ ROS levels shot up and several signs of 
senescence became apparent. Without the protein, cells also moved 
less and wouldn’t roll up into tubes, suggesting that angiogenesis as 
well as homeostasis was affected.
To gauge prohibitin-1’s effects on angiogenesis in vivo, the 
team injected mice with small amounts of a gel that contains the 
blood vessel growth promoter VEGF. Endothelial cells swarmed into 
the gel—unless it also contained RNAi that blocks prohibitin-1. The 
rapid increase in ROS following prohibitin-1 loss was caused by 
depolarization of the mitochondria membranes, suggesting that 
prohibitin-1 somehow maintains membrane integrity. 
Reference: Schleicher, M., et al. 2008. J. Cell Biol. 180:101–112.
Normal levels of a sodium 
channel (red, top) are reduced 




in control cells (top) 
than in cells lacking 
prohibitin-1 (bottom).
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